Not enough Covid-19 vaccine will be available for everyone in the world by 2024, says Serum CEO Adar Poonawalla
 Serum CEO Adar Poonawalla |
Meanwhile, Union Health Minister Dr Harsh Vardhan said yesterday that the vaccine against corona would be available early next year, adding that the vaccine may be ready by the first of the Three months of next year. The next day, Punawala expressed this opinion.
INDIA
LONDON: By the end of 2024, there will not be enough vaccines for every human being in the world to deal with the coronavirus. That is what Adar Punawala said. The chief executive of the Serum institute of india (CII), the world's largest vaccine maker, estimates that if two doses of the vaccine were to be given, about 15 billion doses would be needed for all people around the world. With that in mind, he said, it would take 4-5 years for all the inhabitants of the planet to get vaccinated.
The Pune-based pharmaceutical company has partnered with five international pharmaceutical companies, including AstraZeneca and Novavax, to develop effective vaccines against Covid-19. They have promised to make 100 crore doses. They also said that half of it is allocated for india. Meanwhile, Union Health Minister Dr Harsh Vardhan said yesterday that the vaccine against corona would be available early next year, adding that the vaccine may be ready by the first quarter of next year.The next day, Punawala expressed this opinion.
He said about the promise of making 100 crore doses of serum, their capacity is much higher than other vaccine manufacturers. That said, I know the whole world wants to have hope, but I haven't heard of anyone close to our target yet.
Research for coronavirus vaccine
According to The Financial Times, a British business newspaper, according to an agreement with AstraZeneca, Serum wants to develop a vaccine for six countries at a cost of about 3 per dose. According to their agreement with NovaVax for 92 countries, the same price will be charged for each dose of vaccine. The newspaper claimed that it could even join hands with Russia's Gamelia Research institute to develop a serum Sputnik vaccine.
 Research for coronavirus vaccine: the human trial of the Oxford vaccine |
AstraZeneca suspended the human trial of the Oxford vaccine last week after a participating British volunteer fell ill. Serum also temporarily suspended the trial in india after the Drug Controller of india issued a show cause notice. Although the trial has resumed in Britain.